LEX-WK-0PNK56YTcrawled 2022-03-30 08:52Z
Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR
Jennifer P. Nock · Alvin Lee · Biosimilars Law Bulletin · Published March 30, 2022
Work details
- author
- Jennifer P. Nock · Alvin Lee
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Intellectual Property
- published
- 2022-03-30
Citation
Jennifer P. Nock, Alvin Lee, Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR, Biosimilars Law Bulletin (March 30, 2022) [The Library at LexBlog, LEX-WK-0PNK56YT, lexpid.org/0PNK56YT]